SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-003526
Filing Date
2019-11-12
Accepted
2019-11-12 07:31:06
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT phio_10q-093019.htm 10-Q 324243
2 phio_ex0301.htm EX-3.1 60559
3 INCENTIVE PLAN phio_ex1001.htm EX-10.1 78924
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER phio_ex3101.htm EX-31.1 6851
5 CERTIFICATION phio_ex3201.htm EX-32.1 3655
  Complete submission text file 0001683168-19-003526.txt   2164813

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE phio-20190930.xml EX-101.INS 290461
7 XBRL SCHEMA FILE phio-20190930.xsd EX-101.SCH 23114
8 XBRL CALCULATION FILE phio-20190930_cal.xml EX-101.CAL 36099
9 XBRL DEFINITION FILE phio-20190930_def.xml EX-101.DEF 103390
10 XBRL LABEL FILE phio-20190930_lab.xml EX-101.LAB 208680
11 XBRL PRESENTATION FILE phio-20190930_pre.xml EX-101.PRE 167671
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 191206100
SIC: 2834 Pharmaceutical Preparations